{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:06:07Z","timestamp":1791324367172,"version":"4.3.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270200"],"award-info":[{"award-number":["82270200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000195"],"award-info":[{"award-number":["82000195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070203"],"award-info":[{"award-number":["82070203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770210"],"award-info":[{"award-number":["81770210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M721981"],"award-info":[{"award-number":["2022M721981"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2018CXGC1213"],"award-info":[{"award-number":["2018CXGC1213"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Translational Research Grant of NCRCH","award":["2020ZKMB01"],"award-info":[{"award-number":["2020ZKMB01"]}]},{"name":"Translational Research Grant of NCRCH","award":["2021WWB02"],"award-info":[{"award-number":["2021WWB02"]}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201909184"],"award-info":[{"award-number":["tsqn201909184"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tspd20230610"],"award-info":[{"award-number":["tspd20230610"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH094"],"award-info":[{"award-number":["ZR2020QH094"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. ZR2024MH050"],"award-info":[{"award-number":["No. ZR2024MH050"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH094"],"award-info":[{"award-number":["ZR2020QH094"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["2019QL018"],"award-info":[{"award-number":["2019QL018"]}]},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["2020RC007"],"award-info":[{"award-number":["2020RC007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disorders of lipid metabolism are critical factors in the progression of chronic lymphocytic leukemia (CLL). However, the characteristics of lipid metabolism and related regulatory mechanisms of CLL remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Hence, we identified altered metabolites and aberrant lipid metabolism pathways in patients with CLL by ultra-high-performance liquid chromatography-mass spectrometry-based non-targeted lipidomics. A combination of transcriptomics and lipidomics was used to mine relevant target molecule and downstream signaling pathway. In vitro cellular assays, quantitative real-time polymerase chain reaction (qRT-PCR), western blot, fluorescent staining, RNA sequencing, and coimmunoprecipitation were used to monitor the molecular levels as well as to explore the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant differences in the content of 52 lipid species were identified in CLL samples and healthy controls. Functional analysis revealed that alterations in glycerolipid metabolism, glycerophospholipid metabolism, sphingolipid metabolism, and metabolic pathways had the greatest impact on CLL. On the basis of the area under the curve value, a combination of three metabolites (phosphatidylcholine O-24:2_18:2, phosphatidylcholine O-35:3, and lysophosphatidylcholine 34:3) potentially served as a biomarker for the diagnosis of CLL. Furthermore, utilizing integrated lipidomic, transcriptomic, and molecular studies, we reveal that ectonucleotide pyrophosphatase\/phosphodiesterase 2 (ENPP2) plays a crucial role in regulating oncogenic lipogenesis. ENPP2 expression was significantly elevated in patients with CLL compared with normal cells and was validated in an independent cohort. Moreover, ENPP2 knockdown and targeted inhibitor PF-8380 treatment exerted an antitumor effect by regulating cell viability, proliferation, apoptosis, cell cycle, and enhanced the drug sensitivity to ibrutinib. Mechanistically, ENPP2 inhibited AMP-activated protein kinase (AMPK) phosphorylation and promoted lipogenesis through the sterol regulatory element-binding transcription factor 1 (SREBP-1)\/fatty acid synthase (FAS) signaling pathway to promote lipogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, our findings unravel the lipid metabolism characteristics of CLL. Moreover, we demonstrate a previously unidentified role and mechanism of ENPP2 in regulation of lipid metabolism, providing a novel therapeutic target for CLL treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11658-024-00675-6","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:16:56Z","timestamp":1735305416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["ENPP2 promotes progression and lipid accumulation via AMPK\/SREBP1\/FAS pathway in chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"29","author":[{"given":"Liyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"675_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","volume":"104","author":"L Scarfo","year":"2016","unstructured":"Scarfo L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169\u201382.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"675_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-022-00292-z","volume":"11","author":"Y Nie","year":"2022","unstructured":"Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol. 2022;11(1):39.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"675_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153\u201361.","journal-title":"Cell Metab"},{"issue":"11","key":"675_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"key":"675_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.exphem.2021.12.193","volume":"106","author":"LA Thurgood","year":"2022","unstructured":"Thurgood LA, Best OG, Rowland A, Lower KM, Brooks DA, Kuss BJ. Lipid uptake in chronic lymphocytic leukemia. Exp Hematol. 2022;106:58\u201367.","journal-title":"Exp Hematol"},{"issue":"4","key":"675_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000510768","volume":"144","author":"P Smolewski","year":"2021","unstructured":"Smolewski P, Robak T. Current treatment of refractory\/relapsed chronic lymphocytic leukemia: a focus on novel drugs. Acta Haematol. 2021;144(4):365\u201379.","journal-title":"Acta Haematol"},{"issue":"1","key":"675_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-022-00357-5","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Lu X, Li J, Miao Y. Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma. Biomark Res. 2022;10(1):17.","journal-title":"Biomark Res"},{"issue":"3","key":"675_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41375-018-0366-8","volume":"33","author":"PH Nguyen","year":"2019","unstructured":"Nguyen PH, Niesen E, Hallek M. New roles for B cell receptor associated kinases: when the B cell is not the target. Leukemia. 2019;33(3):576\u201387.","journal-title":"Leukemia"},{"issue":"2","key":"675_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2443.2006.00924.x","volume":"11","author":"S Koike","year":"2006","unstructured":"Koike S, Keino-Masu K, Ohto T, Masu M. The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells. 2006;11(2):133\u201342.","journal-title":"Genes Cells"},{"issue":"3","key":"675_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tips.2011.12.004","volume":"33","author":"H Nishimasu","year":"2012","unstructured":"Nishimasu H, Ishitani R, Aoki J, Nureki O. A 3D view of autotaxin. Trends Pharmacol Sci. 2012;33(3):138\u201345.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"675_CR11","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/oby.21232","volume":"23","author":"VL Reeves","year":"2015","unstructured":"Reeves VL, Trybula JS, Wills RC, Goodpaster BH, Dube JJ, Kienesberger PC, et al. Serum Autotaxin\/ENPP2 correlates with insulin resistance in older humans with obesity. Obesity (Silver Spring). 2015;23(12):2371\u20136.","journal-title":"Obesity (Silver Spring)"},{"key":"675_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biochi.2013.04.010","volume":"96","author":"C Rancoule","year":"2014","unstructured":"Rancoule C, Dusaulcy R, Treguer K, Gres S, Attane C, Saulnier-Blache JS. Involvement of autotaxin\/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. Biochimie. 2014;96:140\u20133.","journal-title":"Biochimie"},{"issue":"2","key":"675_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/path.4379","volume":"234","author":"S Sioletic","year":"2014","unstructured":"Sioletic S, Czaplinski J, Hu L, Fletcher JA, Fletcher CD, Wagner AJ, et al. c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas. J Pathol. 2014;234(2):190\u2013202.","journal-title":"J Pathol"},{"issue":"21","key":"675_CR14","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.3390\/cancers14215437","volume":"14","author":"A Drosouni","year":"2022","unstructured":"Drosouni A, Panagopoulou M, Aidinis V, Chatzaki E. Autotaxin in breast cancer: role, epigenetic regulation and clinical implications. Cancers (Basel). 2022;14(21):5437.","journal-title":"Cancers (Basel)."},{"issue":"11","key":"675_CR15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/cancers11111626","volume":"11","author":"E Kaffe","year":"2019","unstructured":"Kaffe E, Magkrioti C, Aidinis V. Deregulated lysophosphatidic acid metabolism and signaling in liver cancer. Cancers (Basel). 2019;11(11):1626.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"675_CR16","doi-asserted-by":"publisher","first-page":"101042831769454","DOI":"10.1177\/1010428317694544","volume":"39","author":"M Quan","year":"2017","unstructured":"Quan M, Cui JJ, Feng X, Huang Q. The critical role and potential target of the autotaxin\/lysophosphatidate axis in pancreatic cancer. Tumour Biol. 2017;39(3):1010428317694544.","journal-title":"Tumour Biol"},{"issue":"4","key":"675_CR17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/10428194.2021.2010055","volume":"63","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang L, Xu T, Zhao X, Jiang X, Xiao F, et al. Aberrant ENPP2 expression promotes tumor progression in multiple myeloma. Leuk Lymphoma. 2022;63(4):963\u201374.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"675_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12870-018-1412-4","volume":"18","author":"C Yu","year":"2018","unstructured":"Yu C, Luo X, Zhan X, Hao J, Zhang L, YB LS, et al. Comparative metabolomics reveals the metabolic variations between two endangered Taxus species (T. fuana and T. yunnanensis) in the Himalayas. BMC Plant Biol. 2018;18(1):197.","journal-title":"BMC Plant Biol"},{"issue":"5","key":"675_CR19","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/ijms19051471","volume":"19","author":"Y Li","year":"2018","unstructured":"Li Y, Fang J, Qi X, Lin M, Zhong Y, Sun L, et al. Combined analysis of the fruit metabolome and transcriptome reveals candidate genes involved in flavonoid biosynthesis in Actinidia arguta. Int J Mol Sci. 2018;19(5):1471.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"675_CR20","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446\u201356.","journal-title":"Blood"},{"issue":"11","key":"675_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41419-021-04368-2","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Hu X, Yun X, Liu J, Yang J, Tian Z, et al. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death Dis. 2021;12(11):1083.","journal-title":"Cell Death Dis"},{"issue":"1","key":"675_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-022-00364-0","volume":"12","author":"X Hu","year":"2023","unstructured":"Hu X, Han Y, Liu J, Wang H, Tian Z, Zhang X, et al. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia. Exp Hematol Oncol. 2023;12(1):6.","journal-title":"Exp Hematol Oncol"},{"issue":"41","key":"675_CR23","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1038\/s41388-018-0333-x","volume":"37","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhou X, Li Y, Xu Y, Lu K, Li P, et al. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia. Oncogene. 2018;37(41):5520\u201333.","journal-title":"Oncogene"},{"key":"675_CR24","doi-asserted-by":"publisher","first-page":"1114582","DOI":"10.3389\/fimmu.2023.1114582","volume":"14","author":"CK Keerthana","year":"2023","unstructured":"Keerthana CK, Rayginia TP, Shifana SC, Anto NP, Kalimuthu K, Isakov N, et al. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Front Immunol. 2023;14:1114582.","journal-title":"Front Immunol"},{"issue":"18","key":"675_CR25","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.3390\/cancers13184557","volume":"13","author":"D Avsec","year":"2021","unstructured":"Avsec D, Jakos Djordjevic AT, Kanduser M, Podgornik H, Skerget M, Mlinaric-Rascan I. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cells. Cancers (Basel). 2021;13(18):4557.","journal-title":"Cancers (Basel)."},{"issue":"13","key":"675_CR26","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3390\/nu14132669","volume":"14","author":"D Verrelli","year":"2022","unstructured":"Verrelli D, Dallera L, Stendardo M, Monzani S, Pasqualato S, Giorgio M, et al. Hydroxycitric acid inhibits chronic myelogenous leukemia growth through activation of AMPK and mTOR pathway. Nutrients. 2022;14(13):2669.","journal-title":"Nutrients"},{"key":"675_CR27","doi-asserted-by":"publisher","first-page":"105661","DOI":"10.1016\/j.biocel.2019.105661","volume":"118","author":"JP Sah","year":"2020","unstructured":"Sah JP, Hao NTT, Han X, Tran TTT, McCarthy S, Oh Y, et al. Ectonucleotide pyrophosphatase 2 (ENPP2) plays a crucial role in myogenic differentiation through the regulation by WNT\/\u03b2-Catenin signaling. Int J Biochemi Cell Biol. 2020;118:105661.","journal-title":"Int J Biochemi Cell Biol"},{"issue":"4","key":"675_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/bjh.15427","volume":"182","author":"D Prieto","year":"2018","unstructured":"Prieto D, Seija N, Uriepero A, Souto-Padron T, Oliver C, Irigoin V, et al. LPL protein in chronic lymphocytic leukaemia have different origins in mutated and unmutated patients. Advances for a new prognostic marker in CLL. Br J Haematol. 2018;182(4):521\u20135.","journal-title":"Br J Haematol"},{"issue":"5","key":"675_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1541-7786.MCR-14-0412","volume":"13","author":"U Rozovski","year":"2015","unstructured":"Rozovski U, Grgurevic S, Bueso-Ramos C, Harris DM, Li P, Liu Z, et al. Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res. 2015;13(5):944\u201353.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"675_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40164-022-00302-0","volume":"11","author":"Z Wu","year":"2022","unstructured":"Wu Z, Gu D, Wang R, Zuo X, Zhu H, Wang L, et al. CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p\/LPL axis. Exp Hematol Oncol. 2022;11(1):51.","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"675_CR31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/ATVBAHA.122.317682","volume":"42","author":"E Karshovska","year":"2022","unstructured":"Karshovska E, Mohibullah R, Zhu M, Zahedi F, Thomas D, Magkrioti C, et al. Endothelial ENPP2 (ectonucleotide pyrophosphatase\/phosphodiesterase 2) increases atherosclerosis in female and male mice. Arterioscler Thromb Vasc Biol. 2022;42(8):1023\u201336.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"675_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01809-1","volume":"17","author":"I Plastira","year":"2020","unstructured":"Plastira I, Bernhart E, Joshi L, Koyani CN, Strohmaier H, Reicher H, et al. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia. J Neuroinflamm. 2020;17(1):1.","journal-title":"J Neuroinflamm"},{"issue":"10","key":"675_CR33","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1080\/15548627.2022.2039000","volume":"18","author":"H-L Yang","year":"2022","unstructured":"Yang H-L, Lai Z-Z, Shi J-W, Zhou W-J, Mei J, Ye J-F, et al. A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence. Autophagy. 2022;18(10):2459\u201380.","journal-title":"Autophagy"},{"issue":"1","key":"675_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.chembiol.2022.12.006","volume":"30","author":"F Salgado-Polo","year":"2023","unstructured":"Salgado-Polo F, Borza R, Matsoukas M-T, Marsais F, Jagerschmidt C, Waeckel L, et al. Autotaxin facilitates selective LPA receptor signaling. Cell Chem Biol. 2023;30(1):69-84.e14.","journal-title":"Cell Chem Biol"},{"key":"675_CR35","doi-asserted-by":"publisher","first-page":"106877","DOI":"10.1016\/j.phrs.2023.106877","volume":"195","author":"J Yan","year":"2023","unstructured":"Yan J, Duan W, Gao Q, Mao T, Wang M, Duan J, et al. ENPP2 inhibitor improves proliferation in AOM\/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition. Pharmacol Res. 2023;195:106877.","journal-title":"Pharmacol Res"},{"issue":"9","key":"675_CR36","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.3390\/ijms24098325","volume":"24","author":"C Magkrioti","year":"2023","unstructured":"Magkrioti C, Kaffe E, Aidinis V. The role of autotaxin and LPA signaling in embryonic development, pathophysiology and cancer. Int J Mol Sci. 2023;24(9):8325.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"675_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","volume":"18","author":"SA Lim","year":"2022","unstructured":"Lim SA, Su W, Chapman NM, Chi H. Lipid metabolism in T cell signaling and function. Nat Chem Biol. 2022;18(5):470\u201381.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"675_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12916-023-03101-4","volume":"21","author":"FM Butler","year":"2023","unstructured":"Butler FM, Utt J, Mathew RO, Casiano CA, Montgomery S, Wiafe SA, et al. Plasma metabolomics profiles in black and white participants of the adventist health study-2 cohort. BMC Med. 2023;21(1):408.","journal-title":"BMC Med"},{"issue":"1","key":"675_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-019-1484-5","volume":"18","author":"SC Moore","year":"2020","unstructured":"Moore SC. Metabolomics and breast cancer: scaling up for robust results. BMC Med. 2020;18(1):18.","journal-title":"BMC Med"},{"issue":"1","key":"675_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12916-023-02740-x","volume":"21","author":"L Chen","year":"2023","unstructured":"Chen L, Mir SA, Bendt AK, Chua EWL, Narasimhan K, Tan KM-L, et al. Plasma lipidomic profiling reveals metabolic adaptations to pregnancy and signatures of cardiometabolic risk: a preconception and longitudinal cohort study. BMC Med. 2023;21(1):53.","journal-title":"BMC Med"},{"issue":"1","key":"675_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12916-022-02457-3","volume":"20","author":"A Altuna-Coy","year":"2022","unstructured":"Altuna-Coy A, Ruiz-Plazas X, S\u00e1nchez-Martin S, Ascaso-Til H, Prados-Saavedra M, Alves-Santiago M, et al. The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell\u2019s metabolic crosstalk. BMC Med. 2022;20(1):255.","journal-title":"BMC Med"},{"issue":"1","key":"675_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12916-017-0968-4","volume":"15","author":"J-S Zheng","year":"2017","unstructured":"Zheng J-S, Sharp SJ, Imamura F, Koulman A, Schulze MB, Ye Z, et al. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. BMC Med. 2017;15(1):2.","journal-title":"BMC Med"},{"issue":"4","key":"675_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/10428194.2015.1106533","volume":"57","author":"U Rozovski","year":"2016","unstructured":"Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z. Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma. 2016;57(4):758\u201365.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"675_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.leu.2405058","volume":"22","author":"CP Pallasch","year":"2008","unstructured":"Pallasch CP, Schwamb J, Konigs S, Schulz A, Debey S, Kofler D, et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia. 2008;22(3):585\u201392.","journal-title":"Leukemia"},{"issue":"5","key":"675_CR45","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.jlr.2023.100370","volume":"64","author":"A Chattopadhyay","year":"2023","unstructured":"Chattopadhyay A, Mukherjee P, Sulaiman D, Wang H, Girjalva V, Dorreh N, et al. Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis. J Lipid Res. 2023;64(5):100370.","journal-title":"J Lipid Res"},{"issue":"1","key":"675_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1051\/jbio:2006010","volume":"200","author":"JS Saulnier-Blache","year":"2006","unstructured":"Saulnier-Blache JS. Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue. J Soc Biol. 2006;200(1):77\u201381.","journal-title":"J Soc Biol"},{"issue":"21","key":"675_CR47","doi-asserted-by":"publisher","first-page":"11958","DOI":"10.3390\/ijms222111958","volume":"22","author":"M Panagopoulou","year":"2021","unstructured":"Panagopoulou M, Fanidis D, Aidinis V, Chatzaki E. ENPP2 methylation in health and cancer. Int J Mol Sci. 2021;22(21):11958.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"675_CR48","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.3390\/ijms23073717","volume":"23","author":"M Panagopoulou","year":"2022","unstructured":"Panagopoulou M, Drosouni A, Fanidis D, Karaglani M, Balgkouranidou I, Xenidis N, et al. ENPP2 promoter methylation correlates with decreased gene expression in breast cancer: implementation as a liquid biopsy biomarker. Int J Mol Sci. 2022;23(7):3717.","journal-title":"Int J Mol Sci"},{"key":"675_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.745990","volume":"8","author":"W Deng","year":"2021","unstructured":"Deng W, Chen F, Zhou Z, Huang Y, Lin J, Zhang F, et al. Hepatitis B virus promotes hepatocellular carcinoma progression synergistically with hepatic stellate cells via facilitating the expression and secretion of ENPP2. Front Mol Biosci. 2021;8: 745990.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"675_CR50","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11011-018-0233-3","volume":"33","author":"RP Cholia","year":"2018","unstructured":"Cholia RP, Dhiman M, Kumar R, Mantha AK. Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes. Metab Brain Dis. 2018;33(4):1307\u201326.","journal-title":"Metab Brain Dis"},{"key":"675_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101315","volume":"28","author":"MH Kim","year":"2020","unstructured":"Kim MH, Seong JB, Huh JW, Bae YC, Lee HS, Lee DS. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling. Redox Biol. 2020;28: 101315.","journal-title":"Redox Biol"},{"issue":"6","key":"675_CR52","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66(6):789\u2013800.","journal-title":"Mol Cell"},{"issue":"11","key":"675_CR53","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/ijms19113344","volume":"19","author":"NR Janzen","year":"2018","unstructured":"Janzen NR, Whitfield J, Hoffman NJ. Interactive roles for AMPK and glycogen from cellular energy sensing to exercise metabolism. Int J Mol Sci. 2018;19(11):3344.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"675_CR54","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/molecules22122083","volume":"22","author":"D Prieto","year":"2017","unstructured":"Prieto D, Oppezzo P. Lipoprotein lipase expression in chronic lymphocytic leukemia: new insights into leukemic progression. Molecules. 2017;22(12):2083.","journal-title":"Molecules"},{"issue":"5","key":"675_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/ejh.12789","volume":"97","author":"A Rombout","year":"2016","unstructured":"Rombout A, Verhasselt B, Philippe J. Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications. Eur J Haematol. 2016;97(5):409\u201315.","journal-title":"Eur J Haematol"},{"key":"675_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ebiom.2016.11.033","volume":"15","author":"L McCaw","year":"2017","unstructured":"McCaw L, Shi Y, Wang G, Li YJ, Spaner DE. Low density lipoproteins amplify cytokine-signaling in chronic lymphocytic leukemia cells. EBioMedicine. 2017;15:24\u201335.","journal-title":"EBioMedicine"},{"key":"675_CR57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fonc.2013.00236","volume":"3","author":"SR Bhave","year":"2013","unstructured":"Bhave SR, Dadey DY, Karvas RM, Ferraro DJ, Kotipatruni RP, Jaboin JJ, et al. Autotaxin inhibition with PF-8380 enhances the radiosensitivity of human and murine glioblastoma cell lines. Front Oncol. 2013;3:236.","journal-title":"Front Oncol"},{"issue":"19","key":"675_CR58","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1021\/acschemneuro.2c00046","volume":"13","author":"S Roy","year":"2022","unstructured":"Roy S, Chakrabarti M, Dasgupta H, Mahale A, Tripathi S, Sharma V, et al. Inhibition of autotaxin ameliorates LPA-mediated neuroinflammation and alleviates neurological dysfunction in acute hepatic encephalopathy. ACS Chem Neurosci. 2022;13(19):2829\u201341.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"675_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/en.2017-00035","volume":"158","author":"K D\u2019Souza","year":"2017","unstructured":"D\u2019Souza K, Kane DA, Touaibia M, Kershaw EE, Pulinilkunnil T, Kienesberger PC. Autotaxin is regulated by glucose and insulin in adipocytes. Endocrinology. 2017;158(4):791\u2013803.","journal-title":"Endocrinology"},{"issue":"8","key":"675_CR60","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2174\/1568009616666160408150032","volume":"16","author":"L Smolej","year":"2016","unstructured":"Smolej L. Refractory chronic lymphocytic leukemia: a therapeutic challenge. Curr Cancer Drug Targets. 2016;16(8):701\u20139.","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"675_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12931","volume":"92","author":"SS Skanland","year":"2020","unstructured":"Skanland SS, Karlsen L, Tasken K. B cell signalling pathways-new targets for precision medicine in chronic lymphocytic leukaemia. Scand J Immunol. 2020;92(5): e12931.","journal-title":"Scand J Immunol"},{"issue":"11","key":"675_CR62","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood-2017-02-763516","volume":"129","author":"L Busque","year":"2017","unstructured":"Busque L. HSPCs are marathon and not sprint relay athletes. Blood. 2017;129(11):1406\u20137.","journal-title":"Blood"},{"issue":"5","key":"675_CR63","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/cancers12051328","volume":"12","author":"B George","year":"2020","unstructured":"George B, Chowdhury SM, Hart A, Sircar A, Singh SK, Nath UK, et al. Ibrutinib resistance mechanisms and treatment strategies for B-cell lymphomas. Cancers (Basel). 2020;12(5):1328.","journal-title":"Cancers (Basel)."},{"issue":"7","key":"675_CR64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00277-017-2973-2","volume":"96","author":"V Kaur","year":"2017","unstructured":"Kaur V, Swami A. Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib. Ann Hematol. 2017;96(7):1175\u201384.","journal-title":"Ann Hematol"},{"issue":"4","key":"675_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41408-021-00467-7","volume":"11","author":"N Timofeeva","year":"2021","unstructured":"Timofeeva N, Gandhi V. Ibrutinib combinations in CLL therapy: scientific rationale and clinical results. Blood Cancer J. 2021;11(4):79.","journal-title":"Blood Cancer J"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-024-00675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-024-00675-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-024-00675-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:02:17Z","timestamp":1735311737000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-024-00675-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1186\/s11658-024-00675-6","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study using human tissues was approved by Shandong Provincial Hospital\u2019s medical ethical committee (approval no. 2021-217, date: 1 March 2021). Informed consent was obtained for the collection of all samples in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}